Quantcast

Latest Infliximab Stories

2012-05-22 02:30:15

New research being presented at Digestive Disease Week® (DDW) offers key insights into the prevention and treatment of bowel diseases, which affect millions of people worldwide. Several studies show that factors, including common dietary additives, hormone replacement therapy, oral contraceptives and even high-altitude travel may cause or exacerbate these diseases. Other research examines the effect of cutting-edge therapies on ulcerative colitis and Crohn's disease, collectively known as...

2012-04-03 10:06:28

The American College of Rheumatology (ACR) has released the 2012 recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) and biologic agents in the treatment of rheumatoid arthritis (RA). The guidelines published today in the ACR journal, Arthritis Care & Research, are an update to the 2008 recommendations and address the issues of initiating and switching drugs, screening for tuberculosis (TB) reactivation, immunization, and the use of biologics in high-risk RA...

2012-01-18 21:55:19

Early, aggressive treatment may help reduce symptoms and improve joint function Medications or biologic agents that target T-cells, white blood cells involved in the body´s immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). About 7.5...

2011-11-07 11:37:17

As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares. "We need to do more studies to see if more pharmacologically-based timing of when...

2011-11-05 23:30:00

According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma. Chicago, Illinois (PRWEB) November 05, 2011 According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related